Abbott Laboratories

NYSE:ABT   3:59:58 PM EDT
+0.41 (+0.37%)
5:20:26 PM EDT: $111.62 -0.27 (-0.24%)

FDA Says About 18,677 Cans Of Similac Advance 2’-FL Stage 1 Expected In Mid-July From Abbott Nutrition (Ireland)

Published: 06/28/2022 18:22 GMT
Abbott Laboratories (ABT) - FDA Says About 18,677 Cans of Similac Advance 2’-fl Stage 1 Expected in Mid-july From Abbott Nutrition (ireland).
FDA Says Exercising Enforcement Discretion for the Importation of the Infant Formula Products of Abbott Nutrition (ireland).
FDA Says Abbott to Reserve Part of Inventory to Provide Free Product for Critical Needs to Special Supplemental Nutrition Program for Wic Agencies.
FDA Says Abbott to Use Online Outlets Like, and Others to Maximize Availability Nationwide for Balance of Product.
Further Company Coverage: Abtn ((reuters.